This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Gene therapy and nanotechnology based CNS targeted vectors
Investments > €500k
European Commission
Motor neurone diseases|Spinal muscular atrophy (SMA)
2016